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Innovation in Diabetes ± October 2014 
 
Ref. Title Name 
1 MyDiabetesMyWay Patient Portal Deborah Wake 
2 MyDiabetesMyWay e-learning hub (Moodle) Deborah Wake 
3 
SCI-diabetes/ MDMW Communication Portal- Tools for Remote 
Communication/ Consultation 
Deborah Wake 
4 
Risk Modelling for Care Planning- integration into Informatics 
Dashboard for Clinical Use. 
Deborah Wake 
5 
Access to Chronic Medication Service (CMS) and Pharmaceutical 
Care Planning 
Diane Smith 
6 Medication and Lifestyle Coaching Diane Smith 
7 Multi-media Diabetes Resources Diane Smith 
8 Promoting Diabetes Education Diane Smith 
9 Tele-Pharmacy  Diane Smith 
10 Understanding my diabetes medication Diane Smith 
11 Pharmaceutical Industry and Medical Technology (PIMTs) Grahame Cumming 
12 
An on-line and interactive education system for young people with 
type 1 diabetes to understand self-management for their lifestyle 
Jacqui Charlton 
13 
Proof of Concept study to deliver personalised use of information to 
support diabetes management and behaviour change; right 
information; right time; right way.  
Sandra Macrury 
14 Virtual promotion of physical activity for people with type 2 diabetes Sandra Macrury 
15 
Remote foot ulcer management: RAPID (Reducing Amputation in 
People with Diabetes)  
Sandra Macrury 
16 Diabetic foot screening ± development of technology  Sandra Macrury 
17 
Portable capillary HbA1c testing for diagnosis and self-monitoring of 
diabetes. Possibility of mobile phone adaption for testing 
Sandra Macrury 
18 
Web app for decision support for patients with type 1 diabetes 
undertaking sport or exercise 
Sandra Macrury 
19 Online level 3 structured education for type 1 diabetes Sandra Macrury 
20 
My Diabetes My Way electronic personal health record ± uptake at 
scale 
Scott Cunningham 
21 TeleClinics for diabetes Scott Williamson 
22 
Develop a diabetes sim / game in which the main character has 
diabetes. Young people need to keep the sim / character alive as they 
face the various challenges of life or the game.  
Steve Birnie 
23 
Development of meaningful automated glucose data to in-patient 
clinical areas  
Stuart Ritchie 
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24 
In-patient Care: Integrated eHealth solutions to improve patient care, 
safety and outcomes. 
Brian Kennon 
25 
,QQRYDWLYHPRGHORIFDUHWRDGGUHVVWKHµSURFHVVRIFDUH¶LQPDQDJLQJ
people with long term conditions 
Brian Kennon 
26 Young Persons Remote Clinic Consultation Hillary Shand 
27 
Maximise use of the data to support self-management of patients with 
co-morbidities 
George Dodds 
28 Virtual practice outreach and education in primary care Sam Phillip 
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Innovation 
MyDiabetesMyWay Patient Portal 
 
Provides online data access (health care records) for all patients in 
Scotland with Diabetes displayed using lpatient friendly 
visualisations. Also offers access to a massive online education 
resources site (interactive games/ videos/ written info via website), 
with tailoring of educational links depending on patients clinical 
characteristics. 
 
Problem 
Improving self management/ patient empowerment for all patients in 
NHS Scotland 
 
Benefits 
Improved diabetes outcomes, and reduced complications. 
Improving patient knowledge, quality of life and motivation. 
 
Costs ± Development  
Basic Patient Portal already developed- running costs around 
£150k/ annum, but see planned development below 
 
Timescale 
Now 
New development e.g. integration with 3rd party apps and products 
(Apple/ uMotif/ wearable tech etc)- over 12 months. 
Implementation costs 
Ongoing running cost for basic MDMW portal around £150k/ yr . 
Additional cost for future developments. 
Risks 
Risk- poor uptake by patients in Scotland (recruitment has been 
slower than expected). Ongoing funding risk- currently funded partly 
by ehealth leads/ Scottish Diabetes Group on an annual basic- no 
long term guarantee 
 
Partners 
Opportunities to work with industry partners to allow MDMW to 
gather additional data from 3rd party apps and wearable technology 
and to allow data display back into other apps/ mobile technology 
e.g. uMotif app and Apple health kit app (ongoing conversations 
with both). 
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Innovation MyDiabetesMyWay e-learning hub (Moodle) 
Problem 
Jacqui Charlton (DSN Lothian) is working with the 
MyDiabetesMyWay Team) to develop some structured online 
education programmes to support self management of diabetes as 
an adjunct or an alternative to traditional face to face patient 
education.  These will be delivered through an elearning platform 
called moodle that will be integrated into MDMW, Whilst MDMW 
already provides some patients resources these are not provided in 
a structured way. These e-learning resource allow patients to work 
through a structured series of material on a particular topic and 
include interactive elements. Health Care Professions could enrol 
patients onto courses depending on their needs. 
 
Benefits 
Provision of education that can be completed in patients own time ± 
flexible learning without need for face to face contact.  
 
Costs ± Development  
£10k has been made available for development of the platform and 
some connect development for type 1 diabetes (young patients) 
A further £20-40k would be required to develop further modules for 
both type 1 and type 2 diabetes. 
 
Timescale 6 months- type 1 elearning module will be ready 
(Further 18 months to fund and develop wider diabetes modules 
including type 2) 
 
Implementation costs 
Running costs around £20k/ year (nationally) 
£5-10k/ yr for patient and HCP engagement  
Risks 
Poor engagement of patients 
Poor engagement of health care professionals ± HCPs need to 
recommend to patients 
Loss of technical team from MDMW due to lack of funding. 
 
Partners 
Current partnership between MDMW team and Jacqui Charlton. No 
third party provider. A third party provider could be considered to 
run this, however this is likely to be expensive and the skills are 
already present in house (MDMW tea,). 
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Innovation 
SCI-diabetes/ MDMW Communication Portal- Tools for Remote 
Communication/ Consultation 
 
To allow the development and use of tools for patient-HCP 
communication, such as Skype style clinics, email service/ online 
messaging for non urgent queries, online discussion groups 
(education), and home upload of blood glucose monitor readings for 
sharing with health care professionals. Plan to capture 
communication and data flow through SCI-diabetes/ MDMW 
platform. 
 
We are also working closely with United for Health who are doing 
some similar work focusing on home blood glucose upload (using 
Diasend s third party SME). 
Problem 
It is costly and time consuming for patients to attend clinic and face 
to face education. Some of this care could be delivered more 
flexibly and remotely using communication tools that are now widely 
available. 
 
Benefits 
Improved quality of life, quality of care, flexibility and satisfaction for 
patients. Reduced costs of care (less face to face consultations) 
Costs ± Development  Around £103K given by SDG to support a pilot in 4 health care 
areas (NHS Tayside, Lothian, Grampian and Lanarkshire) 
Timescale We are 12 months into a 24 month pilot which has been funded by 
the Scottish Diabetes Group. Following this (around Dec 2015- Feb 
2016), we hope the tools will be available for national use, but this 
will require ongoing funding. 
 
Implementation costs Implementation and Running Costs: 
Home glucose upload (Diasend) accounts- costs nationally (around 
Scotland)- around £100k/ annum 
Support and technical management of other remote communication 
tools - £50k/ annum 
 
Risks 
Risks- poor uptake by patients, poor engagement with clinical staff, 
inability to change rigid clinic structures/ credit not given to staff for 
remote communication work. 
 
Partners 
We are already partnering with DIASEND (commercial SME) re 
blood glucose upload and working with the NHS Scotland National 
Video Conferencing Service re : Skype style clinics. 
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Innovation 
Risk Modelling for Care Planning- integration into Informatics 
Dashboard for Clinical Use. 
 
To allow the development of risk models and integration into online 
dashboards, that allow the prediction of which individuals/ patient 
groups are likely to be at risk of complications/ admission/ adverse 
events.  Allow care to be tailored to those in need at an early stage. 
This would also allow development of individual care pathways for 
screening etc. 
 
Problem 
Complication rates and admission rates for diabetes are hugely 
costly. Early intervention could reduce such costly care episodes. 
Care provision can be individualised. 
 
Benefits 
Improved quality of care, reduced costs of care (Admissions / 
complications). 
Costs ± Development  
Risk algorithm development- some already developed/ some would 
need developing- needs close collaboration between academic 
groups and industry 
 
New risk algorithm development _ ??£1-300k (needs further 
discussion with academic groups) 
 
IT dashboard development - £100k 
 
Dashboard could be based on existing algorithms initially and 
adapted as new algorithms become available 
 
Timescale 12 months- dashboard development 
24-36 months- ongoing algorithm development for more risk 
prediction tools 
 
 
Implementation costs Implementation and Running Costs: 
 
Dashboard running costs for Scotland (?50k-100k)- depends whether 
being done in house or by 3rd party. 
 
Risks 
Risks- Defining IP/ establishing collaboration/ ability to produce good 
algorithms 
Uptake and use of product by HCPS/ managers etc 
eHealth policies re integration of products into existing system 
 
Partners 
Aridhia Informatics are interested in developing diabetes risk apps 
both in Scotland and other settings. This was discussed in relation to 
a TSB bid (between Aridhia and academic partners e.g. University of 
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Dundee (Helen Colhouns group) and SCI- diabetes team), but the 
IXQGLQJELGZDVQ¶WVXLWDEOHJLYHQWKHZHLJKWLQJRIFRVWVWRZDUGV
academia. There remains an opportunity for collaboration I this area, 
and development of a commercial product to be used in Scotland 
and wider with a revenue share to all parties. 
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Name of Innovation 
Access to Chronic Medication Service (CMS) and Pharmaceutical Care Planning 
 
Pharmaceutical Companies may have some IT solutions around how to make the technology 
WKDWVXSSRUWV&06DELW³VOLFNHU´DQGPRUHXVHUVIULHQGO\LHFRXOGWKHIXQFWLRQDOLW\RIWKHSDWLHQW
access site of My Diabetes My Way include the Pharmaceutical Care Plan.  
 
In addition as the Community Pharmacists has a role to play in supporting people with diabetes, 
could limited access to SCI ± Diabetes (e.g. biochemistry results, medication history, 
cardio/renal and lifestyle) be made available to Pharmacies who provide CMS? 
 
Problem 
x Partial completion of the Pharmaceutical Care Plan due to lack of information 
x Poor Glycaemic Control and quality of life 
 
Benefits 
x Pharmacists are more knowledgeable about the person with diabetes and better support 
them with regards to their medication 
x Improved Glycaemic Control and quality of life 
x Person centred 
 
Development costs 
Unknown 
 
 
Timescale 
Dependent on workload for SCI ±Diabetes and other related IT systems (funding resources) 
 
 
Implementation costs 
Unknown 
 
 
Risks 
Information Governance with SCI ±Diabetes and Community Pharmacists 
 
 
Partners 
SCI ± Diabetes, other related IT providers NHS Boards and Community Pharmacy 
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Name of Innovation 
Medication and Lifestyle Coaching 
 
To provide some form of medication and lifestyle coaching/review for the individual with 
diabetes possibly via General Practice, Keep Well, or Weight Management Programmes 
(Leisure Services) and or Pharmacy which is triggered by changes in the persons medication 
regimen. Life style coaching should be offered to all those with long term conditions, possibly a 
prolonged programme of information, access to gym/personal trainer and full lifestyle advice 
may be an option along with medication review. This programme could also be adapted for 
those with pre-diabetes or family history of diabetes. 
Problem 
x Poor life style choices 
x Poor Glycaemic control 
x Poorer outcomes 
 
Benefits 
x Improved Glycaemic Control 
x Improved life style choices (behaviour change) 
x Better self management 
x Improved outcomes 
 
Development costs 
Keep Well currently provide brief interventions on alcohol, tobacco, weight and mental health. 
Weight management programme (Weigh to Go Ayrshire) 12 week programme delivered by 
Leisure Services and other trained professionals. 
 
 
Timescale 
Unknown 
 
 
Implementation costs 
Weigh to Go Ayrshire (£5k per year- covers about 80 attendees) 
Keep Well - Unknown 
 
Risks 
Services continue as they are. Many at breaking point as more and more  people are diagnosed 
with diabetes 
 
Partners 
Boards, MCNs, Pharmacy, Keep Well, Leisure Services and Public Health 
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Name of Innovation 
Multi-media Diabetes Resources 
 
Utilise the expertise of drug companies to produce videos/ DVDs/ CDs/ You Tube, computer 
streaming etc., to provide information in various formats around medicines used to treat 
diabetes; why and how they should be taken, possible side effects, where to go to find more 
information, e.g. single source i.e. My Diabetes My Way. This could be used by various 
healthcare professionals as tools to signpost patients.   
 
Problem 
 
x Health literacy 
x Carers level of understanding of medication 
 
Benefits 
 
Takes into account where people with diabetes may have literacy problems, e.g. where patients 
may not be able to read information leaflets. Also very useful for carers, both paid and unpaid, 
to increase their understanding and knowledge about the medicines their clients/family may be 
taking 
 
Development costs 
 
unknown 
 
Timescale 
 
Company dependent 
 
Implementation costs 
If resources are already available by individual pharmaceutical companies websites is it 
possible to directly transfer these to My Diabetes My Way to reduce costs 
 
Risks 
 
Access to hardware. However this potentially could be supported by co-production with local 
libraries or Third Sector Organisations who have public access IT facilities 
 
Partners 
NHS Boards, Pharmaceutical Companies and My Diabetes My Way (Public Libraries and Third 
Sector Organisations) 
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Name of Innovation 
Promoting Diabetes Education 
 
People with diabetes need to be encouraged to attend any educational sessions around 
managing their medicines and condition. To attract people we need to set out our stall better (it 
is not just about informing the person with diabetes it is about drawing them in, finding the 
hook).  Linking this with care planning, anticipatory care and the talking points agenda would 
give us the best returns and hopefully support medicine compliance and better diabetes 
outcomes. These are skills we recognise as being available within the Pharmaceutical 
companies and would like to tap into to help improve attendance at education. 
Problem 
This is lacking in our own services and think this is reflected in the lack of attendance at 
educational events.  
 
Benefits 
x Knowledgeable person with diabetes who is better able to self-manage 
x Optimal Staff utilisation for education events 
 
 
Development costs 
Unknown 
 
 
Timescale 
Unknown 
 
 
Implementation costs 
:RXOG3KDUPDFHXWLFDOFRPSDQLHVFRQVLGHUSURYLGLQJDµPDUNHWHU¶IRUHDFK%RDUGWRZRUNZLWK
MCN Education Lead and local Communications Department? The cost of the new materials 
developed would be met by the Boards 
 
 
Risks 
Continued poor attendance at education events where staff time is not being fully utilised. 
People with diabetes are not fully educated about their condition and are unable to self-manage 
successfully 
 
Partners 
Pharmaceutical FRPSDQLHV1+6%RDUGV0&1¶VDQGORFDO&RPPXQLFDWLRQ'HSDUWPHQWV 
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Name of Innovation 
Tele-Pharmacy ± development of links within patient information leaflets to a service that would 
trigger text-message reminder alerts to encourage people with diabetes to take their medicine at 
the appropriate times ± patient centred approach 
 
Problem 
 
x Poor Glycaemic control 
x Medication compliance 
x Medicine wastage 
 
Benefits 
 
x Improved glycaemic control and quality of life 
x Compliance  
x Reduction in medicine waste 
 
Development costs 
 
Unknown 
(Florence (FLO) system developed by NHS Stoke on Trent provides 37,500 texts for £10.5k) 
 
Timescale 
 
Company dependent  
 
Implementation costs 
 
Limited for NHS however will have an impact on individual companies 
 
Risks 
 
Potential for inequality due to lack of hardware 
 
Partners 
 
Pharmaceutical companies and NHS and Community Pharmacy, IT Partners, possibly SCI-
Diabetes 
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Name of Innovation 
Understanding my diabetes medication 
 
What would be useful to People with diabetes is a workshop or a resource which explains in 
easy to understand language the whole issue of medication, what has been prescribed, how it 
works and why it is important to take it correctly (compliance, titration etc).  Also included would 
be, what if I miss a dose, does it impact on any other medication I have been prescribed.  It 
would address side effects and questions to ask GP, PN, DSN, Consultant and Community 
Pharmacy. 
 
Problem 
The issue of understanding and taking prescribed medication effectively is a common theme 
occurring in our self management programmes.  
 
Benefits 
As a person centred approach, people with diabetes will be empowered and in the driving seat 
in terms of managing their medication.  The interactions between people with diabetes and 
acute, primary care staff and community pharmacists will be improved and enhanced.  This 
should result in improved compliance and reduction in waste.  This resource could be designed 
as an enhancement of the Diabetes Conversation Maps which are a core part of patient 
education. 
 
Development costs 
Healthyi ©, Lily Diabetes Care would need to be approached for this development (could the 
eLearning on Diabetes Medication provided via the Scottish Government and the Virtual 
College be adapted for use by people with diabetes) 
 
Timescale 
Soon ± within two years 
 
Implementation costs 
There will be an investment of NHS staff and volunteer time to roll out the new resource once 
completed.  
 
Risks 
Investment of time from interested parties and securing additional funds to produce the 
resource. 
 
Partners 
Diabetes MCN, Community Pharmacists, NHS Boards, Healthyi © and Lily Diabetes Care 
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Name of Innovation 
Pharmaceutical Industry and Medical Technology (PIMTs) 
 
A joint Pharmaceutical Industry and Medical Technology sector collaboration with the NHS and 
citizens to enhance the opportunities for people to be more informed about diabetes and take 
the appropriate and relevant actions for prevention and or better self-management of their 
condition. 
 
Problem 
There has historically been a "silo" approach taken by the NHS and industry to the support that 
is provided to citizens in the prevention and subsequent self management of diabetes in both 
its forms.   
 
The involvement of citizens in the design of services to support them in their management of 
diabetes, has been limited and tends to deliver solutions geared to whole populations rather 
than tailored to individuals.  
 
This approach to service redesign can often also re-enforce the silo approach to service 
delivery ± with individual services only contributing to the redesign of their part of the pathway ± 
rather than being involved in looking at the whole continuum of care. 
 
$VDFRQVHTXHQFHSHRSOH¶VDELOLW\WRSUHYHQW7\SHGLDEHWHVDQGVHOIPDQDJHERWK7\Se 1 
and 2 can be difficult, if they fall into the gaps between service delivery silos ± resulting in 
potential increased incidence of the disease and a consequent increased demand on health 
and other statutory services.    
 
Benefits 
By taking a collaborative approach to the future delivery of patient centred services, there will 
be the opportunity for both the pharmaceutical and medical technology industries to deliver 
products, whose design has been influenced through the ongoing engagement with: 
x A range of citizens who will identify what their needs are and what the range of  
³DSSURDFKHV´UHTXLUHWREHWKDWZLOOHQDEOHWKHPLQGLYLGXDOO\WRKDYHDVXVWDLQHGDSSURDFK
to adopting preventative  life style choices with enhanced self management capability , 
and  
x A range of clinicians who can outline what is required to innovate the services that they 
provide to their patients, whilst at the same time providing clinical expertise in evaluating 
suggestions being put forward by citizens and industry partners.     
 
Development costs 
The main cost will be that which is required to support the setting up and running of the 
collaborative design workshops which will seek to capture innovative ideas as a result of multi 
stakeholder engagement. 
 
Funding will be required to prototype new technologies / medications and to pilot new pathways 
of service delivery, with the evaluation of these then determining their ability to meet the 
required outcomes determined by service users and clinicians.  
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Pharmaceutical Industry and Medical Technology (PIMTs) (cont.) 
 
Timescale 
Once started this process will be ongoing, but subject to a requirement to have some early 
successes around the glucose monitoring and medication management part of the existing 
pathways. 
 
An improved combined model to the delivery of improvements to these parts of the pathway will 
be looked for within the first six months of this collaborative project ± replicating the Digital 
Health Institute workshop approach to deliver this. 
 
After six months and the initial evaluation of the effectives of the changes delivered, the 
collaborative model will then be tasked to identify a range of new potential innovative 
approaches across the care pathway.      
 
Implementation costs 
The enhancements to existing service delivery and the proposed future innovative 
developments will all require to be funded through resource release as the consequence of 
achieving: 
 
x More effective services in terms of both cost and clinical outcomes, 
x A reduction in the demand for NHS provided resources. 
 
Risks 
The main risks will be: 
 
x Ensuring that this model continually has the agility to maintain change at the required 
pace and with the ability to quickly try out and evaluate new approaches, and take the 
learning from these to the next stage*,  
x Ensuring that all stakeholders retain an ³RSHQ FROODERUDWLYH´ DSSURDFK WR WKHLU
engagement in the process, so that there is always on going transparency and trust 
 
* All of this within a Governance Framework that provides for the flexibility to engage with 
citizens using a range of mediums / approaches and that supports innovative change, rather 
than stifles it.   
 
Partners 
There will be representation from: 
x Citizens (both those with diabetes and those for whom effective preventative measures 
will avoid or delay onset), 
x Third sector representatives. 
x Pharmaceutical Industry and Medical Technology (including digital communication) 
companies, 
x Clinicians and NHS staff involved in managing the processes for service delivery, 
x Academia, including the College of Art Design Department. 
x Scottish Government departments and agencies. 
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Innovation 
An on-line and interactive education system for young people 
with type 1 diabetes to understand self-management for their 
lifestyle.  
 
Young people are a challenging age group for care delivery. Diabetes 
education, monitoring and support from Health Care Professionals 
(HCPs) is essential to achieve acceptable blood glucose control for 
wellbeing, and prevention of acute and long-term complications. 
Education is traditionally delivered face-to-face in a hospital setting. 
Digital-based education is a novel alternative that would allow young 
people to learn at a pace and time to suit, with guidance and support 
from a HCP via email/phone.  This intervention would be situated 
within My Diabetes My Way, with access by personal log-in. A home 
page would provide general Type 1, with separate sections for topics 
including daily activities (exercise, alcohol, employment, sex and 
contraception etc.), and acute and long-term complications.  
Each topic will have a step through interactive module with key 
questions to instigate thoughts around personal situations, self-
management strategies and evaluation of effectiveness. Delivery 
tools include digital presentations, on-line activities for reinforcement 
e.g. checking glucose before and after exercise, and written feedback 
to aid understanding /empowerment. Further information will be given 
as word documents, patient stories, video clips, links to publications 
(via MDMW or other websites). Digital communication with healthcare 
professionals and peers will support learning. 
 
Problem 
Type 1 patient education is a fundamental part of treatment and care, 
and is currently provided either face to face by a HCP, or using 
leaflets, or non-validated websites.  
However, digital based education that is developed by HCPs and 
people with Type 1 diabetes, would ensure relevant, accurate, 
evidence-based information, in a user-friendly format. This 
information can be accessed by young people whenever, and 
wherever they wish. On-line education may reduce the need for 
hospital attendance, thus reducing costs and time off school / work for 
patients. Patients with social phobias and those living remotely may 
also prefer this delivery method. 
 
Benefits 
This is an innovative approach to education and patient support, 
based on established technology and common modes for people 
locating general information and social networking. This has potential 
to improve: the glycaemic control and wellbeing of individual patients, 
current DNA rates of patients attending diabetes appointments, and 
also communication between patient and HCP by using internet 
resources.  This would not totally replace face-to-face appointments 
with HCPs for clinic appointments, but would provide an alternate 
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resources/ method of engagement which may particularly appeal to 
young people and socially isolated patients who have disengaged 
from traditional care.  
 
Costs ± Development   
Timescale The system will be written by Spring 2015, and hopefully evaluated 
by a small number of patients and HCPs regarding the content, 
structure and appearance. 
 
2QFH³OLYH´WKHV\VWHPZLOOQHHGWKHEHORZHYDOXDWLRQ 
 
Implementation costs Would need evaluation regarding the impact on glycaemic control 
and quality of life. 
Evaluate around HCPs regarding the time, and benefits of using the 
system with a patient compared to only face-to-face education. 
 
Risks 
HCPs not using it. 
Lack of advertising. 
YP not engaging with the system. 
 
Partners  
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Innovation 
Proof of Concept study to deliver personalised use of information to 
support diabetes management and behaviour change; right 
information; right time; right way.  
 
Remote Diabetes clinic delivering care via digital technology interaction, 
comprising evaluation of diabetes self-efficacy and self-care and 
technology acceptability:  
Home or Office VC consultation (WebEx)  
Text and Email support  
Remote sharing of BG data 
 
Problem 
Remote and rural landscape  
Long return waiting list appointments  
Poor glycaemic control especially in type 1 diabetes 
Significant patient and staff travelling times 
 
Benefits 
 Improved flexibility around appointments & engagement with HCPs 
(medical, nursing, dietetic staff)  
 Personal needs driven service  
 Enhanced self management and behaviour change  
 Improved glycaemic control  
 Reduce hospital admission and outpatient attendance  
 Reduced patient and staff travelling times 
 
Costs ± 
Development  
Project is currently funded 
Timescale Project is currently funded 
Implementation 
costs 
Integration to current diabetes services is envisaged  
Licensing costs - difficult to estimate for technologies developed and 
external to NHS  
Costs of support for text use will be non disciple specific should be 
attributed to eHealth budgets across boards 
 
Risks 
NHS eHealth endorsement and support for all modalities of interaction  
Local IT issues ± broadband access 
 
Partners 
Telecoms: Need reliable platform for personalised VC  
Informatics/Tech company: Robust and cost effective system for remote 
BG transmission from evolving BG monitoring devices 
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Innovation Virtual promotion of physical activity for people with type 2 diabetes 
Problem 
Poor adherence to healthy lifestyle behaviours in diabetes, physical 
activity in particular  
Difficulties in accessing information about how and where to engage in 
physical activity, especially in remote and rural localities 
 
Benefits 
Improved physical activity participation based on behaviour change theory  
Improved glycaemic control  
Enhanced self-management  
Weight loss 
 
Costs ± 
Development  
Project is currently funded 
Timescale - Now (within 6 months). Results suggest positive outcomes for the 
interactive arm of the study (RCT) 
 
Implementation 
costs 
This innovation reflects several research projects that have incorporated 
co-design with people who have type 2 diabetes.  It offers the opportunity 
to be further developed as a national resource to not only aid management 
of diabetes through a behaviour change model but also prevention of 
diabetes and the opportunity for a population-wide approach to improve 
physical activity levels based on application of local information. 
 
Risks 
Local IT issues ± internet/broadband access  
Support for web site maintenance  
Maintaining accurate and up to date information on local physical activity 
access maps 
 
Partners 
Informatics/Tech company:  
Further develop for diabetes prevention, overweight and sedentary 
population  
Consider development of mobile phone app version 
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Innovation 
Remote foot ulcer management: RAPID (Reducing Amputation in 
People with Diabetes) 
 
Access to generic foot email with image review for advice from specialist 
services to facilitate triage of cases  
Real time, two way tele-consultation clinic with MDT based on innovative 
hard & software for remote home consultation 
 
Problem 
High lower limb amputation rates for people with diabetes  
Need for timely referral to multidisciplinary foot team  
Difficulties in accessing appropriate services, especially in remote and 
rural localities  
Travel times for patients and staff 
 
Benefits 
 Reduce local amputation rates for diabetes patients  
 Reduce ineffective or inappropriate travel time for people with diabetic 
foot ulceration  
 Promote collaborative working between community and specialist 
teams  
 Potential for extrapolation to other acute or chronic conditions for 
community-based monitoring and linkage to specialist services 
 
Costs ± 
Development  
Costs for proof of concept need to be more fully estimated, about £15-
20,000 assuming NHS in kind costs 
 
Timescale - Soon (within 1 year).  
Proof of Concept study required, thereafter implemented at larger scale 
with further evaluation of technology use along with ROI assessment 
 
Implementation 
costs 
Costs would reflect number of hardware units Scotland-wide (no cost 
available at present), plus licensing costs for software. 
 
Risks 
Engagement of local community services, podiatry, nursing  
Costs and maintenance of hardware devices  
Licensing costs for software support 
 
Partners 
Currently in discussion with IT company who have necessary hard and 
software to deliver this project 
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Innovation 
Diabetic foot screening ± development of technology for HCP or self-
recording to facilitate accurate sensory and pressure measurement at 
annual screening in order to detect early warning signs, improve risk 
assessment estimation and prevent diabetic foot problems. Devices would 
link to patient records to upload results. 
 
Problem 
Routine annual foot screening for people with diabetes utilises crude 
testing mechanisms with inconsistent application  
Foot risk status is poorly recorded by non specialists with potential for 
consequences including increased diabetic foot ulceration and ultimately 
amputations. 
 
Benefits 
 Increase diabetic foot screening rates  
 Increase accuracy of foot risk status recording  
 Improve patient self-awareness of foot risk status  
 Improve referral to orthotic services for pressure offloading devices 
and footwear  
 Reduce diabetic foot ulceration  
 Reduce amputation rates for diabetes patients 
 
Costs ± 
Development  
NHS in kind costs for initial exploration of concept; currently in early 
stages with NHS Highland 
 
Timescale Longer (within 2-3 years).  
Requires development, testing and validation of prototype 
 
Implementation 
costs 
Costs would reflect number of devices Scotland-wide. 
Risks 
Development of a sufficiently accurate, portable device to be universally 
accepted 
 
Partners Bioengineering/IT company 
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Innovation 
Portable capillary HbA1c testing for diagnosis and self-monitoring of 
diabetes. Possibility of mobile phone adaption for testing 
 
Problem 
HbA1c monitoring entails costs related to travel and number of visits for 
patients in primary care. Real time measurement with capillary samples in 
secondary care is expensive. 
Benefits 
Reduce unnecessary travel and associated visits to primary or secondary 
care sites  
Potential to reduce primary care costs and/or allow diversion of resource 
to other priorities  
Potential to reduce secondary care costs  
HbA1c is a more convenient test for diagnosis of type 2 diabetes or at risk 
individuals 
Costs ± 
Development  
Preliminary testing of capillary testing using filter paper successfully 
undertaken. Feasibility required for community study.  Funding required for 
analytical chemistry exploration of Hb fragment extraction and glycated 
component estimate compared with HPLC methodology.  Need to explore 
potential for mobile phone adaption. Health economic analysis 
Timescale Longer (within 2-3 years).  
Requires development, testing and validation of prototype 
Implementation 
costs 
&RVWVZRXOGUHIOHFWGHYHORSPHQWRIµNLWV¶IRUdistribution across site and /or 
adapted phone technology. 
Risks 
Development of a sufficiently accurate, portable device to be universally 
accepted  
Costs at scale 
Partners Analytical chemists; bioengineering; cellular phone company 
 
 
18 
 
Innovation 
Web app for decision support for patients with type 1 diabetes 
undertaking sport or exercise 
 
Problem 
People with type 1 diabetes are dissuaded from undertaking increased 
physical activity due to problems in managing insulin and food intake. 
Benefits 
 Reduce sedentary time and increase benefits of physical activity  
 Reduce errors in insulin or carbohydrate adjustment for sport or 
exercise  
 Improve well being  
 Reduce episodes of hypoglycaemia  
 Decision support for self-management 
Costs ± 
Development  
Software platform development and feasibility testing with use of CGMS 
(Libre) and Actigraph monitoring about £10,000 
Timescale Soon (within 1 year). 
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Implementation 
costs 
Cost to maintain software  
Evaluation of innovation at scale costs 
Risks 
Product developed not useful leading to high attrition rate  
Competition from other products  
Identifying support for maintenance costs 
Partners In discussion with software development company 
 
 
19 
 
Innovation Online level 3 structured education for type 1 diabetes 
Problem 
Difficulties in accessing education for people with type 1 diabetes with work 
commitments that preclude regular attendance and rural communities where 
face to face group sessions are less viable 
Benefits 
Ensure opportunities for access to structured education are equitable  
Improve self management and self reliance 
Costs ± 
Development  
Modular adaption of current structured education by HEI about £10,000  
Feasibility/evaluation testing NHS in kind 
Timescale Soon (within 1 year). 
Implementation 
costs 
Low as complimentary to existing group sessions delivered by NHS 
Risks 
Maintenance and update of course content online  
Poor uptake by type 1 diabetes community 
Partners In discussion with HEI 
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Innovation 
My Diabetes My Way electronic personal health record ± 
uptake at scale 
 
Provides online data access (health care records) for all patients in 
Scotland with Diabetes displayed using patient friendly 
visualisations. Also offers access to a massive online education 
resources site (interactive games/ videos/ written info via website), 
with tailoring of educational links depending on patients clinical 
characteristics. 
 
Problem 
Improving self management/ patient empowerment for all patients in 
NHS Scotland 
Benefits 
Improved diabetes outcomes, and reduced complications. 
Improving patient knowledge, quality of life and motivation. 
Costs ± Development  Basic Patient Portal already developed- running costs around 
£100k/ annum, including planned development below 
Timescale 12 months 
Implementation costs 
Ongoing running cost for basic MDMW portal around £100k/ yr. 
Additional cost for future developments. 
Risks 
Risk- poor uptake by patients in Scotland (recruitment has been 
slower than expected). Ongoing funding risk- currently funded partly 
by eHealth leads/ Scottish Diabetes Group on an annual basic- no 
long term guarantee 
 
Partners 
(QJDJHPHQWZLWK*3¶V$*3LQ+LJKODQGZURWHWRKHUSDWLHQW
caseload and within 2 weeks, uptake of MDMW records access 
increased from 1% to 23%.  Replicating this intervention across 
Scotland would lead to recruitment of around 70,000, making 
significant inroads into the wider population. 3 pilots repeating this 
approach are planned for 2014.  Partnership working would allow us 
to proceed more rapidly across all ~1000 GP sites in Scotland. 
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Name of Innovation 
 
TeleClinics for diabetes 
 
Problem 
High non-attendance rate at young adult diabetes clinics ± 25%-40% DNA rate 
 
 
Benefits 
Improved contact with patients, likelihood of improved diabetes control as a result 
 
 
Development costs 
 
IT costs. Establish the use of teleconf software via patients mobile phone/ tablet or computer.  
Software cost for setting up secure link (e.g. Skype, doctor on demand)  
 
Timescale 
 
Now 
 
Implementation costs 
 
1XUVHUXQQLQJ³FOLQLF´± cost of 0.2 WTE band 6 diabetes nurse. 
 
Risks 
 
Patient confidentiality / data management issues would need addressed 
 
Partners 
 
Local IT dept, software company, Diabetes clinic staff 
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Innovation 
Develop a diabetes sim / game in which the main character has 
diabetes. Young people need to keep the sim / character alive as 
they face the various challenges of life or the game.  
 
Problem 
Engagement of young people with diabetes in their own self-
management, learning about their diabetes through game play. 
Minimising risk taking behaviours by allowing them to try it out in a 
virtual environment. 
Benefits 
By helping young people to understand what the relationship is 
between insulin, food and exercise. 
Help them plan for real life scenarios by challenging them in the 
game. 
Speed up the effects of not looking after their diabetes so 
complications that may take years in the real world could start within 
hours in the game. 
Young people would be involved in developing the game and this 
would also help build their personal engagement with their own 
condition. 
Costs ± Development  
This would depend on the complexity of the game, and to what 
extent this could be supported by an established gaming company. 
£50,000 
Potentially this could be income generating if sold for a minimal 
cost. 
Timescale Once the process of developing the game got started it would 
probably take 6 ± 12 months. The challenge would be creating the 
algorithms to mimic the effects of insulin, food, exercise and the 
other parameters that would impact on the characters diabetes 
control.  
Implementation costs Once developed the resources required to launch and maintain the 
resource would again depend on the type of game produced. In its 
simplest form it would be available as a simple download from the 
apple store (IOS) or play store (Android). 
If more complicated there might be ongoing developer input to 
update the game with new challenges or to fix bugs in the software. 
Risks 
The possible complexity of the simulation, although this could be 
made very simple and range from the very early Tammagochi idea 
to the modern HD game for smart phones. 
<RXQJSHRSOHGRQ¶WOLNHWKHJDPHDQGGRQ¶WHQJDJHZLWKLW 
The development costs are too high 
Partners 
Young people with diabetes 
Young people without diabetes / test game play 
Game developers 
Large established companies looking for good corporate social 
project EA Games, Rockstar etc 
Healthcare professionals 
Writers / animators / higher education establishments 
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23 
 
Innovation 
Development of meaningful automated glucose data to in-patient 
clinical areas  
Problem 
In-patient diabetes management ± both recurrent and inadequately 
managed hypo and hyperglycaemia 
Benefits 
1)Improvement in patient experience and safety.  
2)Improved quality and efficiency through more effective care.  
  
The Diabetes Think, Check, Act programme (formally DiSH) has 
demonstrated the effects of rapid feedback of glucometer data to wards 
and the benefits to inpatient care, particularly around hypoglycaemia. 
Potential economic savings through improved hypoglycaemia and reduced 
length of stay have been explored. 
 
Costs ± 
Development  
 
Timescale +RZORQJXQWLOWKHLQQRYDWLRQLVµER[UHDG\¶" 
 - Now (i.e. within 6 months) ± for existing boards with downloadable 
glucometers 
 - Soon (within 2 years) ± for those without 
  
Implementation 
costs  
Risks 
Boards having the appropriate IT infrastructure including automated 
glucometers (only 6 out of 14 currently have this) for widespread 
dissemination in NHS Scotland 
 
Partners 
Diabetes: Think, Check, Act project, possibly glucometer providers to NHS 
Scotland, alongside potential other interested parties 
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Innovation 
In-patient Care: Integrated eHealth solutions to improve patient care, 
safety and outcomes. Some of the following initiatives already exist in some 
health board areas but standardised care is not available. 
 
Problem 
In-patient diabetes management ± there are ongoing issues with regards the 
early recognition of diabetes, appropriate timely referral, unsafe use of insulin 
and incorrect identification and management of glycaemic extremes.  
Benefits 
Potential innovations: 
1. Timely identification of diabetes:  
a. Remote access for diabetes teams: Utilise existing electronic systems to 
identify patients with diabetes. Developing a real time link between SCI-
diabetes and in patient systems such as trackcare. This could also be linked to 
existing glucometer data to identify those individuals at highest risk with 
repeated extremes of glycemia.  
b. Point of care: ensure the development of electronic admission documents for 
all disciplines includes assessment of diabetes status. Once a patient is 
identified as having diabetes there is a direct link to guidance on which 
individuals require referral to specialist diabetes services. This could also 
include push support to remind healthcare professional to review the risk of 
foot problems in line with the CPR for feet campaign.  
 
2. Support prompt assessment/treatment of glycemic extremes  
a. All point of care blood glucose testing that demonstrates hypoglycaemia 
results in a prompt to treat according to national standardised hypoglycaemia 
algorithms. There would also be a prompt to repeat blood glucose testing to 
ensure hypoglycaemia has resolved. If a recurring problem this could generate 
an automated e mail to specialist diabetes teams to ensure complete capture 
of all individuals with recurrent hypos. This could ensure the correct 
management plan of Treat-Repeat-(Refer). 
b. All point of care blood glucose testing that demonstrates hyperglycaemia 
results in a prompt to test for ketones and assess possible causes for a high 
blood sugar, If a recurring problem this could again generate an automated e 
mail to specialist diabetes teams. 
 
3. Development of a diabetes dashboard: this would provide real time 
information at potentially ward level for specialist and non-specialist HCPs to 
help drive quality improvement. This could include information on in-patients 
with diabetes, frequency and appropriate treatments of hypos, iatrogenic harm 
related to insulin/OHA use and new onset foot lesions etc.  
 
Costs ± 
Development  
Utilise existing systems therefore most costs would be to develop IT links and 
modify glucometer systems. Uncertain at this stage the potential costs. 
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Timescale Some of the above innovations are already in place and therefore there could 
be an evolutionary roll out of these initiatives over a phased two year period. 
The timescale is partly dependent on the ease and development of some of the 
eHealth solutions. 
Implementation 
costs Unknown 
Risks 
All health boards are developing electronic admissions documents and 
solutions have already been identified within the Think-Check-Act Diabetes 
resource.  Failure to ensure these are integrated as part of routine clinical care 
will result in iatrogenic harm from failure to identify patients, lack of appropriate 
referrals, inappropriate management of in-patient diabetes.  
Partners 
Health Boards, SDG, In-patient sub-group of SDG which has lead on the 
development of Diabetes: Think, Check, Act. Glucometer companies, eHealth 
leads nationally and within health boards, informatics companies. 
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Innovation 
,QQRYDWLYHPRGHORIFDUHWRDGGUHVVWKHµSURFHVVRIFDUH¶LQPDQDJLQJ
people with long term conditions.  This would focus on microvascular and 
microvascular screening and could also be combined to address co-morbidities 
in a person centred manner.  
 
Problem 
People living with their long term conditions self manage, for better or worse, 
all the time. Supporting their self-management is a key responsibility of 
everyone involved in health and social carei and up to 80 per cent of 
consultations in primary care involve people living with one or more long term 
health problem. Supporting self-management is a key priority in achieving 
Scotland's 2020 vision for a safe, effective and person centred healthcare 
system where everyone is able to live longer healthier lives at home, or in a 
homely setting. However supporting self-management represents a 
fundamental shift in the relationship between person and healthcare 
professionals.  This can be a challenge for both parties as requires them to 
assume roles that they may be unfamiliar and uncomfortable with. Supporting 
self management for people with long term conditions requires a wider, holistic, 
asset based model that supports side by side, relational interactions that centre 
on the personal goals of the individual. 
 
One of the main barriers to effective consultations and indeed self-
management is the inability within existing health services to deal with 
PXOWLPRUELGLW\DQGDOVRVHSDUDWHWKHµSURFHVVRIFDUH¶IURPPHDQLQJIXO
partnership consultations which focus on agenda and goal setting, the driver 
for improving health.  
 
Benefits 
A. Lifestyle and condition management 
7KHDELOLW\WRDGGUHVVDOODVSHFWVUHODWLQJWRWKHµSURFHVVRIFDUH¶ZLOOLPSURYH
the person centred approach to existing services. It will limit the number of 
appointments that are required which may in turn improve the level of 
engagement. The information from the screening visit can be used to generate 
individualised reports (via SCI-diabetes) that can then be the focus of follow up 
appointments focusing on person specific targets and goal setting. Pre-
consultation reports and combined agenda setting between HCPs and 
individuals are the cornerstones of partnership healthcare and crucial 
developments for improving the management of long term conditions and 
dealing with multiple morbidities. Pilot projects assessing combined 
microvascular screening have shown them to have high satisfaction for 
persons with diabetes. 
B. Reducing routine HCP contact 
$GGUHVVLQJDOODVSHFWVUHODWLQJWRWKHµSURFHVVRIFDUH¶ZLOOOLPLWWKHQXPEHURI
HCP contacts required for each individual. This is not only person centred but 
would also benefit other services such as the Scottish Ambulance Service. In 
addition this would improve the efficiency and effectiveness of care as this 
service can be delivered by suitably trained band 3 health care professionals 
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ensuring that acute and community based diabetes trained HCPs can focus on 
management and outcomes rather than processes of care.   
C. Information transfer 
Utilising the existing SCI-diabetes IT system will ensure timely and appropriate 
transfer of information to all healthcare professionals. In addition this 
information can all be accessed by the person with diabetes via the My 
Diabetes My Way application. This would address the ability to provide pre-
consultation results and greater engagement with health. 
 
Benefits (cont.) 
D. Early detection 
Screening rates for retinopathy are higher than any other potential 
microvascular complication. The lowest rate of screening is for 
microalbuminuria at just over 50% (SDS 2012). Combining screening of all 
microvascular conditions and indeed macrovascular risk factors will allow early 
detection, referral and intervention to limit disease progression and ultimately 
reduce the socioeconomic costs of the long term complications of diabetes. 
 
E. Reduce disengagement 
There is an opportunity to utilise non-NHS space to deliver this care. Utilising 
existing commercial space which offers care outwith traditional hours may 
improve engagement with services and adopting a whole system approach 
may allow partnership working with current providers of healthcare (opticians, 
pharmacy) as well as non-health care providers (supermarkets, retail outlets). 
 
F. Multi-morbidity 
There is no reason which such an initiative should be limited to those 
individuals with diabetes. Modification of the service could allow a similar 
approach to other long terms conditions such as CHD etc.  
 
Costs ± 
Development  
Dependent on the scale of the initiative. Most resources already exist albeit 
some development would be required to allow a fully functional system. 
 
Timescale 
This could be adapted and piloted within 6 months or so.  
Implementation 
costs Unknown 
Risks 
Services continue unchanged and outcomes remain sub-optimal. Ongoing 
failure to address problems with disengagement and multi-morbidity. 
 
Partners 
Health Boards, SDG, House of Care Project SG, Commercial partners, MDMW 
and SCI-Diabetes, Third sector Diabetes UK Scotland. 
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Name of Innovation 
Young Persons Remote Clinic Consultation 
 
The vision is to bring clinics to patients in their home or school, via remote face to face 
consultation. This idea is not meant to substitute clinics but to supplement existing clinic 
schedules.  
7KHVROXWLRQZRXOGQHHGWRFRQVLGHUDµEULQJ\RXURZQGHYLFH¶DSSURDFKRUDSDWLHQWDSSOLFDWLRQ
which could be accessed from their device via the web. 
 
Problem 
The current DNA rate of 10-20% in adolescent and young persons clinics, for NHS Borders is 
an issue. Causes for this include lack of engagement in self-management of condition; also 
travel difficulties given rural location and reluctance to prioritise clinic appointments over 
personal commitments. 
 
Benefits 
Improved contact with patient therefore improved management of condition, empower patients 
in self-management  by contacting them using technology that we know is largely embraced  by 
this age group. 
 
Reduce DNA rate and costs associated, improve control of  long term condition and reduce 
chronic complications associated with the condition and reduce acute hospital admissions with 
acute complications 
 
It generates new business opportunities for companies in an area of technological development 
that is in line with NHS Scotland 20:20 Vision for delivery of care. 
 
Development costs 
To be determined 
 
Timescale 
12-18 months 
 
Implementation costs 
To be determined 
 
Risks 
There may significant Information Governance and Information Technology restrictions that 
need to be considered. 
 
Partners 
 
Patients, Diabetes Team, NHS Borders and solution provider. 
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Innovation 
 
Maximise use of the data to support self-management of 
patients with co-morbidities 
 
Through collaborative working with a number of organisations 
determine how we can maximise use of the data we all have access 
to support self-management of patients with co-morbidities including 
obesity, diabetes,  Chronic Respiratory problems, Angina  
 
Problem 
 
Scotland has lots of different data sets covering different aspects of 
patient care that is not looked at holistically or used to support the 
patient self manage.  
Data sets include national data sets held by ISD (e.g. hospital 
admissions, prescribing data, cost data) 
Personal data gathered as part of other pilot projects (Stormhealth 
have 200 patients with co-morbidities who have provided personal 
data, who are collecting data over a period of time on their 
exercise/diets and who are happy for their data to be used to 
support their longer term health care needs) 
 
Benefits 
 
Identify and resolve issues that may prevent data sharing/linkage to 
establish prototype for collaborative working across health, public 
sector, academia and SMEs 
Develop SURWRW\SH³DSS´EDVHGRQSDWLHQWLGHQWLILHGQHHGVKXPDQ
centred design approach) for this cohort of patients that could be 
used by patients, health care workers etc. 
 
Costs ± Development  
 
:KDWLVWKHHVWLPDWHGFRVWRIPDNLQJWKHLQQRYDWLRQµER[UHDG\¶" 
 
Prototype costs are staff time only 
 
Timescale 
 
+RZORQJXQWLOWKHLQQRYDWLRQLVµER[UHDG\¶" 
 
Estimated 6 months to develop prototype 
 
Implementation costs 
 
Once developed, what is the scale of resource (money/ time/ 
revenue costs) which might be involved in implementing and 
UXQQLQJWKHLQQRYDWLRQRQDµJUHHQILHOGVLWH¶" 
TBC 
 
Risks 
 
What are the risks and barriers to success? 
Key barriers will be around information governance, data protection 
etc.  
Partners 
 
Who is or might be interested/involved in developing the innovation? 
NSS (ISD/PHI, PCF), Lothian Health Board, StormHealth/StormID, 
Health Scotland 
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Innovation 
 
Virtual practice outreach and education in primary care 
1. Develop a module within SCI-diabetes to enhance communication 
between primary care providers and their linked contacts in 
secondary care. 
2. Develop health care provider based case management modules. 
3. Develop better links with existing GP software systems to ensure 
single point of data entry 
4. Develop a shared case management strategy for complex patients 
 
Problem 
 
Most of the people with diabetes are looked after by Primary care. 
Increasingly this care is delivered by practice nurses. There is poor 
uptake of SCI-Diabetes in primary care. 
 
We have been developing a practice outreach programme in 
Grampian and Orkney islands. Have better Case management tools. 
 
Benefits 
 
As part of the Scottish Diabetes Group funded project we are 
developing modules within SCI-Diabetes to enhance telemedicine 
and telesupport. We will build caseload management , better data 
visualisation, personalised recommendations. 
 
1. Ongoing support to SCI-Diabetes development team 
2. better links with primary care including: 
x Nursing homes 
x Prisons 
x Remote locations 
 
Costs ± Development  SCI-Diabetes programmer cost 
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Timescale 
8 Months development 
8 Months Pilot 
Implementation costs 
Practice nurse 
Diabetes specialist nurse 
Risks Resistance from GP software systems to develop links 
Partners  
 
 
                                                        
